The pharmaceutical world is seeing a significant shift in diabetes management with the arrival of GLP-1 skin applications. These devices offer a possibly more user-friendly alternative to shots of GLP-1 drugs, lessening the need for daily needle pricks. The approach delivers the compound directly through the epidermis, arguably enhancing person … Read More